NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC
NCT06966583
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Non Small Cell Lung Cancer
Interventions
DIETARY_SUPPLEMENT:
NAD supplement
RADIATION:
Radiotherapy
DRUG:
Immunotherapy
Sponsor
Sichuan University